Enviar pesquisa
Carregar
Levetiracetam+in+Hepatic+Dysfunction
•
Transferir como PPT, PDF
•
0 gostou
•
584 visualizações
D
dhavalshah4424
Seguir
Vista de apresentação de diapositivos
Denunciar
Compartilhar
Vista de apresentação de diapositivos
Denunciar
Compartilhar
1 de 8
Baixar agora
Recomendados
omega 3
Omega3 cvd
Omega3 cvd
DrSatyabrataSahoo
Effects of Liver disease on Pharmacokinetics
Effects of Liver disease on Pharmacokinetics
Effects of Liver disease on Pharmacokinetics
Areej Abu Hanieh
lithium
Mood stabilising agents
Mood stabilising agents
DrSatyabrataSahoo
vegf inhibitors
Vegf inhibitors
Vegf inhibitors
DrSatyabrataSahoo
Effects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokinetics
Dr. Ramesh Bhandari
warfarin pharmacology, blood thinner, anti-coagulant
Warfarin presentation Hani alghamdi
Warfarin presentation Hani alghamdi
HaniAlghamdi16
a review
Macitentan
Macitentan
Dr. Rupendra Bharti
initiation of warfarin and dose adjustment. how to increase and decrease the doses. INR monitoring for bleeding. food and drug interactions.
Warfarin dosing
Warfarin dosing
Ahmad K
Recomendados
omega 3
Omega3 cvd
Omega3 cvd
DrSatyabrataSahoo
Effects of Liver disease on Pharmacokinetics
Effects of Liver disease on Pharmacokinetics
Effects of Liver disease on Pharmacokinetics
Areej Abu Hanieh
lithium
Mood stabilising agents
Mood stabilising agents
DrSatyabrataSahoo
vegf inhibitors
Vegf inhibitors
Vegf inhibitors
DrSatyabrataSahoo
Effects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokinetics
Dr. Ramesh Bhandari
warfarin pharmacology, blood thinner, anti-coagulant
Warfarin presentation Hani alghamdi
Warfarin presentation Hani alghamdi
HaniAlghamdi16
a review
Macitentan
Macitentan
Dr. Rupendra Bharti
initiation of warfarin and dose adjustment. how to increase and decrease the doses. INR monitoring for bleeding. food and drug interactions.
Warfarin dosing
Warfarin dosing
Ahmad K
An introduction to PCSK-9 inhibitors: a new therapeutic class of drugs approved by US FDA in July 2015 to treat Heterozygous familial hypercholesterolemia (HeFH) and its superiority over gold standard statins in treatment. Does it have potential to become a blockbuster and emulate Lipitor's success?
PCSK-9 inhibitors: The next blockbuster?
PCSK-9 inhibitors: The next blockbuster?
Gaurav Andhansare
g protein
Gprotei npptx
Gprotei npptx
DrSatyabrataSahoo
On 27th Aug 2015, the U.S. Food and Drug Administration approved Evolocumab injection to treat high cholesterol in certain patients.
Fda approves evolocumab
Fda approves evolocumab
Naina Mohamed, PhD
A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia published in NEJM
Evolocumab in hyperlipidemia
Evolocumab in hyperlipidemia
niteshpansari
Case presentation ICH & Prosthetic MV
Case presentation ICH & Prosthetic MV
Kamal Mergani
A 65-year-old man with heart failure and DKA is admitted to hospital with a potassium level of 7.1 mmol/L. HE was started with Rx lisinopril 20 mg daily, spironolactone 25 mg daily. Insulin Infusion + 5% Dextrose
Case discussionseries 2
Case discussionseries 2
PARUL UNIVERSITY
CARBOPLATIN - Drug Information - Taj Pharma, CARBOPLATIN dose Taj pharmaceuticals CARBOPLATINinteractions, Taj Pharmaceutical CARBOPLATIN contraindications, CARBOPLATIN price, CARBOPLATIN Taj Pharma Cancer, oncologyCarboplatin 10 mg/ml Intravenous Infusion SMPC- Taj Pharma . Stay connected to all updated on CARBOPLATIN Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Carboplatin 10 mgml intravenous infusion smpc taj pharmaceuticals
Carboplatin 10 mgml intravenous infusion smpc taj pharmaceuticals
Taj Pharma
My students Shahid Raja and Poulomi Jana had presented this topic in our 22nd Student Scientific Society Conference in the department of Propaedeutic of Internal Diseases No.2
Inhibitors of PCSC9 - indications, class effects, interactions, side effects ...
Inhibitors of PCSC9 - indications, class effects, interactions, side effects ...
OlgaGoryacheva4
A DRUG CAN NOT ONLY CURE THE DISEASE BUT ALSO CAN AGGREVATE THE CONDITION WITHOUT #PharmDoctor
geriatric Case discussion 1
geriatric Case discussion 1
PARUL UNIVERSITY
This presentation includes important factors to be considered prior to deciding anti cancer drugs and dosage
Pharmakokinetics & pharmakodynamics of chemotherapy drugs
Pharmakokinetics & pharmakodynamics of chemotherapy drugs
Srigopal Mohanty
Advices for patients on warfarin
Advices for patients on warfarin
Advices for patients on warfarin
Yapa
Ketoconazole Taj Pharma : Uses, Side Effects, Interactions, Pictures, Warnings, Ketoconazole Dosage & Rx Info | Ketoconazole Uses, Side Effects -: Indications, Side Effects, Warnings, Ketoconazole - Drug Information - Taj Pharma, Ketoconazole dose Taj pharmaceuticals Ketoconazole interactions, Taj Pharmaceutical Ketoconazole contraindications, Ketoconazole price, Ketoconazole Taj Pharma Ketoconazole 200 mg tablets SMPC- Taj Pharma . Stay connected to all updated on Ketoconazole Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Ketoconazole 200 mg tablets smpc taj pharmaceuticals
Ketoconazole 200 mg tablets smpc taj pharmaceuticals
Taj Pharma
Imalek (Imatinib Mesylate Tablets) is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases) and blood problems.
Imalek (Imatinib Mesylate Tablets)
Imalek (Imatinib Mesylate Tablets)
Clearsky Pharmacy
doc. Statins antihyperlipidemics
Statins
Statins
Alaa Fadhel Hassan Alwazni
The phenomenon of complex formation of drug with protein is called as Protein drug binding. The proteins are particularly responsible for such an interaction. A drug can interact with several tissue components.
Protein drug binding
Protein drug binding
Sagar Savale
Evolocumab is a monoclonal antibody and it inhibits Proprotein Convertase Subtilisin/kexin type 9 (PCSK9) to reduce LDL cholesterol in the bloodstream.
Evolocumab - New drug to lower ‘LDL' cholesterol
Evolocumab - New drug to lower ‘LDL' cholesterol
Naina Mohamed, PhD
statins and other newer drugs to treat dyslipidemia all the major categories of hypolypidaemic drugs
Hypolipidaemic vinay
Hypolipidaemic vinay
vinay tuteja
European Medicines Agency document describing grounds for refusal of mipomersen (Kynamro)
Ema scientific conclusions and grounds for refusal of mipomersen
Ema scientific conclusions and grounds for refusal of mipomersen
Marilyn Mann
Pharmacokinetic changes in renal impairment and dosage considerations
Pharmacokinetic changes in renal impairment and dosage considerations
Pharmacokinetic changes in renal impairment and dosage considerations
Dr Htet
TDM of drugs used in organ transplantation, TDM of Cyclosporine
TDM of drugs used in organ transplantation
TDM of drugs used in organ transplantation
Dr. Ramesh Bhandari
Meningomyelocoele
Meningomyelocoele
dhavalshah4424
Dementia-final+++++++++++++++
Dementia-final+++++++++++++++
dhavalshah4424
Mais conteúdo relacionado
Mais procurados
An introduction to PCSK-9 inhibitors: a new therapeutic class of drugs approved by US FDA in July 2015 to treat Heterozygous familial hypercholesterolemia (HeFH) and its superiority over gold standard statins in treatment. Does it have potential to become a blockbuster and emulate Lipitor's success?
PCSK-9 inhibitors: The next blockbuster?
PCSK-9 inhibitors: The next blockbuster?
Gaurav Andhansare
g protein
Gprotei npptx
Gprotei npptx
DrSatyabrataSahoo
On 27th Aug 2015, the U.S. Food and Drug Administration approved Evolocumab injection to treat high cholesterol in certain patients.
Fda approves evolocumab
Fda approves evolocumab
Naina Mohamed, PhD
A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia published in NEJM
Evolocumab in hyperlipidemia
Evolocumab in hyperlipidemia
niteshpansari
Case presentation ICH & Prosthetic MV
Case presentation ICH & Prosthetic MV
Kamal Mergani
A 65-year-old man with heart failure and DKA is admitted to hospital with a potassium level of 7.1 mmol/L. HE was started with Rx lisinopril 20 mg daily, spironolactone 25 mg daily. Insulin Infusion + 5% Dextrose
Case discussionseries 2
Case discussionseries 2
PARUL UNIVERSITY
CARBOPLATIN - Drug Information - Taj Pharma, CARBOPLATIN dose Taj pharmaceuticals CARBOPLATINinteractions, Taj Pharmaceutical CARBOPLATIN contraindications, CARBOPLATIN price, CARBOPLATIN Taj Pharma Cancer, oncologyCarboplatin 10 mg/ml Intravenous Infusion SMPC- Taj Pharma . Stay connected to all updated on CARBOPLATIN Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Carboplatin 10 mgml intravenous infusion smpc taj pharmaceuticals
Carboplatin 10 mgml intravenous infusion smpc taj pharmaceuticals
Taj Pharma
My students Shahid Raja and Poulomi Jana had presented this topic in our 22nd Student Scientific Society Conference in the department of Propaedeutic of Internal Diseases No.2
Inhibitors of PCSC9 - indications, class effects, interactions, side effects ...
Inhibitors of PCSC9 - indications, class effects, interactions, side effects ...
OlgaGoryacheva4
A DRUG CAN NOT ONLY CURE THE DISEASE BUT ALSO CAN AGGREVATE THE CONDITION WITHOUT #PharmDoctor
geriatric Case discussion 1
geriatric Case discussion 1
PARUL UNIVERSITY
This presentation includes important factors to be considered prior to deciding anti cancer drugs and dosage
Pharmakokinetics & pharmakodynamics of chemotherapy drugs
Pharmakokinetics & pharmakodynamics of chemotherapy drugs
Srigopal Mohanty
Advices for patients on warfarin
Advices for patients on warfarin
Advices for patients on warfarin
Yapa
Ketoconazole Taj Pharma : Uses, Side Effects, Interactions, Pictures, Warnings, Ketoconazole Dosage & Rx Info | Ketoconazole Uses, Side Effects -: Indications, Side Effects, Warnings, Ketoconazole - Drug Information - Taj Pharma, Ketoconazole dose Taj pharmaceuticals Ketoconazole interactions, Taj Pharmaceutical Ketoconazole contraindications, Ketoconazole price, Ketoconazole Taj Pharma Ketoconazole 200 mg tablets SMPC- Taj Pharma . Stay connected to all updated on Ketoconazole Taj Pharmaceuticals Taj pharmaceuticals Hyderabad.
Ketoconazole 200 mg tablets smpc taj pharmaceuticals
Ketoconazole 200 mg tablets smpc taj pharmaceuticals
Taj Pharma
Imalek (Imatinib Mesylate Tablets) is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases) and blood problems.
Imalek (Imatinib Mesylate Tablets)
Imalek (Imatinib Mesylate Tablets)
Clearsky Pharmacy
doc. Statins antihyperlipidemics
Statins
Statins
Alaa Fadhel Hassan Alwazni
The phenomenon of complex formation of drug with protein is called as Protein drug binding. The proteins are particularly responsible for such an interaction. A drug can interact with several tissue components.
Protein drug binding
Protein drug binding
Sagar Savale
Evolocumab is a monoclonal antibody and it inhibits Proprotein Convertase Subtilisin/kexin type 9 (PCSK9) to reduce LDL cholesterol in the bloodstream.
Evolocumab - New drug to lower ‘LDL' cholesterol
Evolocumab - New drug to lower ‘LDL' cholesterol
Naina Mohamed, PhD
statins and other newer drugs to treat dyslipidemia all the major categories of hypolypidaemic drugs
Hypolipidaemic vinay
Hypolipidaemic vinay
vinay tuteja
European Medicines Agency document describing grounds for refusal of mipomersen (Kynamro)
Ema scientific conclusions and grounds for refusal of mipomersen
Ema scientific conclusions and grounds for refusal of mipomersen
Marilyn Mann
Pharmacokinetic changes in renal impairment and dosage considerations
Pharmacokinetic changes in renal impairment and dosage considerations
Pharmacokinetic changes in renal impairment and dosage considerations
Dr Htet
TDM of drugs used in organ transplantation, TDM of Cyclosporine
TDM of drugs used in organ transplantation
TDM of drugs used in organ transplantation
Dr. Ramesh Bhandari
Mais procurados
(20)
PCSK-9 inhibitors: The next blockbuster?
PCSK-9 inhibitors: The next blockbuster?
Gprotei npptx
Gprotei npptx
Fda approves evolocumab
Fda approves evolocumab
Evolocumab in hyperlipidemia
Evolocumab in hyperlipidemia
Case presentation ICH & Prosthetic MV
Case presentation ICH & Prosthetic MV
Case discussionseries 2
Case discussionseries 2
Carboplatin 10 mgml intravenous infusion smpc taj pharmaceuticals
Carboplatin 10 mgml intravenous infusion smpc taj pharmaceuticals
Inhibitors of PCSC9 - indications, class effects, interactions, side effects ...
Inhibitors of PCSC9 - indications, class effects, interactions, side effects ...
geriatric Case discussion 1
geriatric Case discussion 1
Pharmakokinetics & pharmakodynamics of chemotherapy drugs
Pharmakokinetics & pharmakodynamics of chemotherapy drugs
Advices for patients on warfarin
Advices for patients on warfarin
Ketoconazole 200 mg tablets smpc taj pharmaceuticals
Ketoconazole 200 mg tablets smpc taj pharmaceuticals
Imalek (Imatinib Mesylate Tablets)
Imalek (Imatinib Mesylate Tablets)
Statins
Statins
Protein drug binding
Protein drug binding
Evolocumab - New drug to lower ‘LDL' cholesterol
Evolocumab - New drug to lower ‘LDL' cholesterol
Hypolipidaemic vinay
Hypolipidaemic vinay
Ema scientific conclusions and grounds for refusal of mipomersen
Ema scientific conclusions and grounds for refusal of mipomersen
Pharmacokinetic changes in renal impairment and dosage considerations
Pharmacokinetic changes in renal impairment and dosage considerations
TDM of drugs used in organ transplantation
TDM of drugs used in organ transplantation
Destaque
Meningomyelocoele
Meningomyelocoele
dhavalshah4424
Dementia-final+++++++++++++++
Dementia-final+++++++++++++++
dhavalshah4424
Dementia-final
Dementia-final
dhavalshah4424
Women
Women
dhavalshah4424
Fractures+Ortho+
Fractures+Ortho+
dhavalshah4424
Diabetes+and+Pregnancy
Diabetes+and+Pregnancy
dhavalshah4424
Arthritis
Arthritis
dhavalshah4424
CAD+And+ACS
CAD+And+ACS
dhavalshah4424
Destaque
(8)
Meningomyelocoele
Meningomyelocoele
Dementia-final+++++++++++++++
Dementia-final+++++++++++++++
Dementia-final
Dementia-final
Women
Women
Fractures+Ortho+
Fractures+Ortho+
Diabetes+and+Pregnancy
Diabetes+and+Pregnancy
Arthritis
Arthritis
CAD+And+ACS
CAD+And+ACS
Semelhante a Levetiracetam+in+Hepatic+Dysfunction
*This work was a group work* - Introduction - Normal liver metabolism. - Liver disease and metabolism - Dosage calculation in case of liver disease
Effect of Liver Disease on Drug Metabolism
Effect of Liver Disease on Drug Metabolism
Mariam Alosfoor
This PPT includes detailed presentation on the topic Effect of Hepatic Diseases on Pharmacokinetics.
EFFECT OF HEPATIC DISEASE ON PHARMACOKINETICS.pptx
EFFECT OF HEPATIC DISEASE ON PHARMACOKINETICS.pptx
Dr. Sabareesh Subramanian A
Antiepileptic in systemic disorder
Antiepileptic in systemic disorder
Antiepileptic in systemic disorder
NeurologyKota
NEWER AED
Levetiracetam
Levetiracetam
Srirama Anjaneyulu
Discussion of clinical pharmacologic (both pharmacokinetic and pharmacodynamic) and points in lung disease.
Drugs pharmacology in liver disease
Drugs pharmacology in liver disease
Mohammad Hadi Farjoo MD, PhD, Shahid behehsti University of Medical Sciences
a concise review of mutual effects of drugs and liver on each other
Drugs pharmacology in liver disease
Drugs pharmacology in liver disease
Mohammad Hadi Farjoo MD, PhD, Shahid behehsti University of Medical Sciences
Pharmacokinetics in liver diseases.
Effects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokinetics
Dr. Ramesh Bhandari
Effect of liver disease on pharmacokinetics --dosage adjustment in hepatic patients therapeutic drug monitoring and clinical pharmacokinetics
Effect of liver disease on pharmacokinetics
Effect of liver disease on pharmacokinetics
pavithra vinayak
I am a pharmacist. These slides describe biotechnology topic. I hope students get more benefits about it. These slides very helpful for the pharmacy department students.
Variation of Pharmacokinetics in disease states-converted-converted.pdf
Variation of Pharmacokinetics in disease states-converted-converted.pdf
UVAS
Dental and oral surgery treatment considerations for patients with liver diseases
Hepatic Considerations In Oral Surgery .pptx
Hepatic Considerations In Oral Surgery .pptx
SudiptaBera9
Here we discussed in detail about the various aspects of branched chain Amino acids in Cirrhosis and few other condition
Branch Chain Amino Acid in Cirrhosis ppt.pptx
Branch Chain Amino Acid in Cirrhosis ppt.pptx
Dr. Awadhesh
GUIDLINES TO CONSIDER WHEN PRESCRIPNING ANALGESICS AND ANTIBIOTICS FOR ELDERLY IN DENTAL PRACTICE
5th y dental special pk consideration in elderly
5th y dental special pk consideration in elderly
KAU
ALF
ALF - Copy.pptx
ALF - Copy.pptx
Nawaf Alshammeri
pharmacology in kidney and liver disease
Drug use in hepatic and renal impairment
Drug use in hepatic and renal impairment
Akshil Mehta
Anticonvulsants are a diverse group of pharmacological agents used in the treatment of epileptic seizures. Charles Locock commented in the Lancet on his use of potassium bromide in 15 cases of "hysterical" epilepsy in young women. The next development was the serendipitous discovery of the anticonvulsant properties of phenobarbital by Alfred Hauptmann in 1912. This predated by more than 20 years the screening of potential therapeutic agents against "electrical seizures" in cats by Houston Merritt and Tracy Putnam. The result was the launching of phenytoin in 1938. Next came primidone, ethosuximide, carbamazepine and valproic acid, all of which can be regarded as first generation antiepileptic drugs (AEDs). Shortly after their synthesis, the benzodiazepines were rapidly recognised as having anticonvulsant activity. The modern era focused on the systematic screening of many thousands of compounds against rodent seizure models under the Anticonvulsant Drug Development Program in the US. This resulted in the global licensing, in chronological order, of vigabatrin, zonisamide, oxcarbazepine, lamotrigine, felbamate, gabapentin, topiramate, tiagabine, levetiracetam, pregabalin and lacosamide.
Anti epileptics-pharmacology and guidelines
Anti epileptics-pharmacology and guidelines
Navya devireddy
Recent advances in antiobesity drugs
Antiobesity drugs.pptx
Antiobesity drugs.pptx
monicaajmerajain
Medicinal Chemistry
Drug metabolism affected by diseases
Drug metabolism affected by diseases
azamushahiullah prottoy
DOSE ADJUSTMENT IN RENAL DISEASE RENAL IMPAIRMENT
Dose adjustment in Renal failure
Dose adjustment in Renal failure
Mallinath Paramgond
Autoimmune liver diseasesmanagement update
Autoimmune liver diseases
Autoimmune liver diseases
Elmuhtady Said FRCP FEBGH
THIS SLIDE GIVES AN INSIGHT TO THE DIFFERENT METHODS THAT COULD BE USED FOR THE DOSAGE ADJUSTMENT IN PATIENTS WITH RENAL DISEASE. RENAL FUNCTION OF THE PATIENT IS ASSESSED TO DETERMINE THE DOSAGE ADJUSTMENT
Dose in uremia
Dose in uremia
Gayathri Kannanunny
Semelhante a Levetiracetam+in+Hepatic+Dysfunction
(20)
Effect of Liver Disease on Drug Metabolism
Effect of Liver Disease on Drug Metabolism
EFFECT OF HEPATIC DISEASE ON PHARMACOKINETICS.pptx
EFFECT OF HEPATIC DISEASE ON PHARMACOKINETICS.pptx
Antiepileptic in systemic disorder
Antiepileptic in systemic disorder
Levetiracetam
Levetiracetam
Drugs pharmacology in liver disease
Drugs pharmacology in liver disease
Drugs pharmacology in liver disease
Drugs pharmacology in liver disease
Effects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokinetics
Effect of liver disease on pharmacokinetics
Effect of liver disease on pharmacokinetics
Variation of Pharmacokinetics in disease states-converted-converted.pdf
Variation of Pharmacokinetics in disease states-converted-converted.pdf
Hepatic Considerations In Oral Surgery .pptx
Hepatic Considerations In Oral Surgery .pptx
Branch Chain Amino Acid in Cirrhosis ppt.pptx
Branch Chain Amino Acid in Cirrhosis ppt.pptx
5th y dental special pk consideration in elderly
5th y dental special pk consideration in elderly
ALF - Copy.pptx
ALF - Copy.pptx
Drug use in hepatic and renal impairment
Drug use in hepatic and renal impairment
Anti epileptics-pharmacology and guidelines
Anti epileptics-pharmacology and guidelines
Antiobesity drugs.pptx
Antiobesity drugs.pptx
Drug metabolism affected by diseases
Drug metabolism affected by diseases
Dose adjustment in Renal failure
Dose adjustment in Renal failure
Autoimmune liver diseases
Autoimmune liver diseases
Dose in uremia
Dose in uremia
Mais de dhavalshah4424
Cardiac+Electrophysiology
Cardiac+Electrophysiology
dhavalshah4424
Hypertension
Hypertension
dhavalshah4424
Management+of+Diabetic+Neuropathy
Management+of+Diabetic+Neuropathy
dhavalshah4424
Legg+Calve+Perthes+Disease
Legg+Calve+Perthes+Disease
dhavalshah4424
Osteoid+Osteoma
Osteoid+Osteoma
dhavalshah4424
Osteoid+Osteoma
Osteoid+Osteoma
dhavalshah4424
Osteoid+Osteoma
Osteoid+Osteoma
dhavalshah4424
Osteoid+Osteoma
Osteoid+Osteoma
dhavalshah4424
Legg+Calve+Perthes+Disease
Legg+Calve+Perthes+Disease
dhavalshah4424
Osteoid+Osteoma
Osteoid+Osteoma
dhavalshah4424
Complications+of+Diabetes
Complications+of+Diabetes
dhavalshah4424
Interventional+Procedures
Interventional+Procedures
dhavalshah4424
Angiogram
Angiogram
dhavalshah4424
Polypharmacy+in+Schizophrenia
Polypharmacy+in+Schizophrenia
dhavalshah4424
Depression+and+Diabetes
Depression+and+Diabetes
dhavalshah4424
Antidepressants+in+Psychiatric+Disorder
Antidepressants+in+Psychiatric+Disorder
dhavalshah4424
Osteoarthritis
Osteoarthritis
dhavalshah4424
Juvenile+Rheumatoid+Arthritis+slides
Juvenile+Rheumatoid+Arthritis+slides
dhavalshah4424
Juvenile+Rheumatoid+Arthritis+slides+
Juvenile+Rheumatoid+Arthritis+slides+
dhavalshah4424
Bipolar+Disorder
Bipolar+Disorder
dhavalshah4424
Mais de dhavalshah4424
(20)
Cardiac+Electrophysiology
Cardiac+Electrophysiology
Hypertension
Hypertension
Management+of+Diabetic+Neuropathy
Management+of+Diabetic+Neuropathy
Legg+Calve+Perthes+Disease
Legg+Calve+Perthes+Disease
Osteoid+Osteoma
Osteoid+Osteoma
Osteoid+Osteoma
Osteoid+Osteoma
Osteoid+Osteoma
Osteoid+Osteoma
Osteoid+Osteoma
Osteoid+Osteoma
Legg+Calve+Perthes+Disease
Legg+Calve+Perthes+Disease
Osteoid+Osteoma
Osteoid+Osteoma
Complications+of+Diabetes
Complications+of+Diabetes
Interventional+Procedures
Interventional+Procedures
Angiogram
Angiogram
Polypharmacy+in+Schizophrenia
Polypharmacy+in+Schizophrenia
Depression+and+Diabetes
Depression+and+Diabetes
Antidepressants+in+Psychiatric+Disorder
Antidepressants+in+Psychiatric+Disorder
Osteoarthritis
Osteoarthritis
Juvenile+Rheumatoid+Arthritis+slides
Juvenile+Rheumatoid+Arthritis+slides
Juvenile+Rheumatoid+Arthritis+slides+
Juvenile+Rheumatoid+Arthritis+slides+
Bipolar+Disorder
Bipolar+Disorder
Levetiracetam+in+Hepatic+Dysfunction
1.
Levetiracetam in Hepatic
Dysfunction
2.
3.
4.
5.
Comparative study of
pharmacokinetic parameters of Levetiracetam Reference: Brockmöller J; PK of levetiracetam in hepatically impaired subjects; Clin Pharmacol Ther. 2005 Jun; 77(6):529-41 [email_address]
6.
7.
8.
[email_address]
Baixar agora